title: Primary amyloidosis with unusual bone involvement: reversibility with melphalan, prednisone, and colchicine.
authors.affiliation: Department of Medicine C, Kaplan Hospital, Rehovot, Israel.
authors.forename: A
authors.initials: A
authors.lastname: Schattner
authors.forename: D
authors.initials: D
authors.lastname: Varon
authors.forename: L
authors.initials: L
authors.lastname: Green
authors.forename: N
authors.initials: N
authors.lastname: Hurwitz
authors.forename: Z
authors.initials: Z
authors.lastname: Bentwich
mesh_terms: D000686:Amyloidosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D001851:Bone Diseases, Metabolic / Q000209:etiology*; D001853:Bone Marrow / Q000473:pathology; D003078:Colchicine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy / Q000209:etiology; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D008558:Melphalan; D003078:Colchicine; D011241:Prednisone